Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 568 followers
Latest posts
Last updated 24 days ago
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status...
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion
Human medicines European public assessment report (EPAR): Riociguat Accord, riociguat, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Riociguat Accord, riociguat, Status: Opinion
Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Status: Opinion
Human medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: Opinion
Human medicines European public assessment report (EPAR): Lyrokaul, lerodalcibep, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Lyrokaul, lerodalcibep, Status: Opinion
Human medicines European public assessment report (EPAR): Lynavoy, Linerixibat, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Lynavoy, Linerixibat, Status: Opinion
Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion
Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Status: Opinion
Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion
24 days ago
Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion